Literature DB >> 22037817

[Fungal nail infections--an update: Part 1--Prevalence, epidemiology, predisposing conditions, and differential diagnosis].

P Nenoff1, G Ginter-Hanselmayer, H-J Tietz.   

Abstract

Onychomycosis describes a chronic fungal infection of the nails most frequently caused by dermatophytes, primarily Trichophyton rubrum. In addition, yeasts (e. g. Candida parapsilosis), more rarely molds (Scopulariopsis brevicaulis), play a role as causative agents of onychomycosis. However, in every case it has to be decided if these yeasts and molds are contaminants, or if they are growing secondarily on pathological altered nails. The point prevalence of onychomycosis in Germany is 12.4%, as demonstrated within the "Foot-Check-Study", which was a part of the European Achilles project. Although, onychomycosis is rarely diagnosed in children and teens, now an increase of fungal nail infections has been observed in childhood. More and more, diabetes mellitus becomes important as significant disposing factor both for tinea pedis and onychomycosis. By implication, the onychomycosis represents an independent and important predictor for development of diabetic foot syndrome and foot ulcer. When considering onychomycosis, a number of infectious and non-infectious nail changes must be excluded. While psoriasis of the nails does not represent a specific risk factor for onychomycosis, yeasts and molds are increasing isolated from patients with psoriatic nail involvement. In most cases this represents secondary growth of fungi on psoriatic nails. Recently, stigmatization and impairment of quality of life due to the onychomycosis has been proven.

Entities:  

Mesh:

Year:  2012        PMID: 22037817     DOI: 10.1007/s00105-011-2251-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  45 in total

1.  [Fungal flora of diseased and healthy toenails].

Authors:  C Seebacher
Journal:  Mykosen       Date:  1968-12-01

2.  [In vitro studies of fungal growth on psoriatic scales--an experimental study].

Authors:  H Pöhler; H Braun; C Schönborn
Journal:  Mykosen       Date:  1968-03-01

3.  The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.

Authors:  N Kaçar; S Ergin; C Ergin; B S Erdogan; I Kaleli
Journal:  Clin Exp Dermatol       Date:  2006-07-04       Impact factor: 3.470

4.  Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case-control study.

Authors:  Jean-Claude Roujeau; Bardur Sigurgeirsson; Hans-Christian Korting; Helmut Kerl; Carle Paul
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

5.  Detection of xanthomegnin in epidermal materials infected with Trichophyton rubrum.

Authors:  A K Gupta; I Ahmad; I Borst; R C Summerbell
Journal:  J Invest Dermatol       Date:  2000-11       Impact factor: 8.551

6.  Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis.

Authors:  Bernadette Manz; Gerhard H Scholz; Helmut Willgerodt; Uwe-Frithof Haustein; Pietro Nenoff
Journal:  Eur J Dermatol       Date:  2002 May-Jun       Impact factor: 3.328

7.  A case-control analysis and laboratory study of the two feet-one hand syndrome in two dermatology hospitals in China.

Authors:  P Zhan; Y P Ge; X L Lu; X D She; Z H Li; W D Liu
Journal:  Clin Exp Dermatol       Date:  2009-10-23       Impact factor: 3.470

8.  Fungal foot infection, cellulitis and diabetes: a review.

Authors:  I R Bristow; M C Spruce
Journal:  Diabet Med       Date:  2009-05       Impact factor: 4.359

Review 9.  Toenail onychomycosis in diabetic patients: issues and management.

Authors:  Peter Mayser; Viviane Freund; Debby Budihardja
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

10.  Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?

Authors:  A Shemer; N Nathansohn; B Kaplan; H Trau
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-03       Impact factor: 6.166

View more
  10 in total

1.  [Onychomycosis : a crown jewel of dermatology].

Authors:  H-J Tietz; P Nenoff
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751

Review 2.  Onychomycosis: modern diagnostic and treatment approaches.

Authors:  Georgi Tchernev; Plamen Kolev Penev; Pietro Nenoff; Liliya Georgieva Zisova; José Carlos Cardoso; Teodora Taneva; Gabriele Ginter-Hanselmayer; Julian Ananiev; Maya Gulubova; Reni Hristova; Desislava Nocheva; Claudio Guarneri; G Martino; Nobuo Kanazawa
Journal:  Wien Med Wochenschr       Date:  2012-09-30

3.  In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.

Authors:  M Ghannoum; N Isham; L Long
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

4.  [Infections of finger and toe nails due to fungi and bacteria].

Authors:  P Nenoff; U Paasch; W Handrick
Journal:  Hautarzt       Date:  2014-04       Impact factor: 0.751

5.  Epidemiology of Dermatophytes in Belgium: A 5 Years' Survey.

Authors:  Sacheli Rosalie; Cuypers Lize; Seidel Laurence; Darfouf Rajae; Adjetey Caroline; Lagrou Katrien; Hayette Marie-Pierre
Journal:  Mycopathologia       Date:  2021-04-26       Impact factor: 2.574

6.  [Molecular biological detection of dermatophytes in clinical samples when onychomycosis or tinea pedis is suspected. A prospective study comparing conventional dermatomycological diagnostics and polymerase chain reaction].

Authors:  I Winter; S Uhrlaß; C Krüger; J Herrmann; G Bezold; A Winter; S Barth; J C Simon; Y Gräser; P Nenoff
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

Review 7.  The Diagnosis and Treatment of Nail Disorders.

Authors:  Uwe Wollina; Pietro Nenoff; Gunter Haroske; Holger A Haenssle
Journal:  Dtsch Arztebl Int       Date:  2016-07-25       Impact factor: 5.594

8.  Fungal nail infections (onychomycosis): a never-ending story?

Authors:  Mahmoud Ghannoum; Nancy Isham
Journal:  PLoS Pathog       Date:  2014-06-05       Impact factor: 6.823

9.  Clinical, epidemiological, and therapeutic profile of dermatophytosis.

Authors:  Carla Andréa Avelar Pires; Natasha Ferreira Santos da Cruz; Amanda Monteiro Lobato; Priscila Oliveira de Sousa; Francisca Regina Oliveira Carneiro; Alena Margareth Darwich Mendes
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

10.  [What agents incriminated in athlete's foot? Survey of consulting diabetic patients in CHU Mohammed VI Marrakech].

Authors:  Hakima Chegour; Nawal El Ansari; Ghizlane El Mghari; Abdelali Tali; Laila Zoughaghi; Majda Sebbani; Mohamed Amine
Journal:  Pan Afr Med J       Date:  2014-03-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.